Profile

Kathleen Rodgers

Professor, Clinical Translational Sciences | Professor, BIO5 Institute | Professor, Pharmacology | Associate Director, Translational Neuroscience | Member of the Graduate Faculty

Pharmacology

Courses(2)

Problem Based Translational Research in Alzheimer's Disease and Related Dementias I
Problem Based Translational Research in Alzheimer's Disease and Related Dementias II

Student Thesis/Dissertation(3)

The Characterization of Peripheral and Neuro-inflammation Utilizing a 5xFAD Mouse Model
2024·masters
Mas Receptor Agonism for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
2024·doctoral
Involvement of Mas in Neuroinflammation
2020·masters

Technologies & Patents(5)

Novel Mouse Strain for Inflammation and Neurodegeneration
2024·Technology
Methods For Treating Or Limiting Development Of Cardiovascular Disease-Related Neurological Disorders
2023·Patent
Treatment of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) with a Polypeptide
2020·Technology
Development of Aptamers Neutralizing Antibodies for Demyelinating Diseases
2018·Technology
Agents, Compositions And Methods For Treating And Preventing Alzheimer’s Disease
1899·Patent

Profile

Kathleen Rodgers

Courses(2)

Problem Based Translational Research in Alzheimer's Disease and Related Dementias I

Problem Based Translational Research in Alzheimer's Disease and Related Dementias II

Student Thesis/Dissertation(3)

The Characterization of Peripheral and Neuro-inflammation Utilizing a 5xFAD Mouse Model

Mas Receptor Agonism for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Involvement of Mas in Neuroinflammation

Technologies & Patents(5)

Novel Mouse Strain for Inflammation and Neurodegeneration

Treatment of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) with a Polypeptide

Development of Aptamers Neutralizing Antibodies for Demyelinating Diseases

Agents, Compositions And Methods For Treating And Preventing Alzheimer’s Disease

News(5)

NIH Grant Advances Research on Women's Brains, Menopause and Alzheimer's Risk

Despite COVID, UArizona Reports Strong Year for Innovation and Commercialization

One Small Molecule, Potential Giant Step to Improve Cognitive Function

Developing a Diverse Workforce To End the Alzheimer’s Epidemic

Building a Pathway from Tribal College to Neuroscience Laboratories